Global Markets Direct’s, ‘FIT Biotech Oy – Product Pipeline Review – 2015′, provides an overview of the FIT Biotech Oy’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of FIT Biotech Oy’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

• The report provides brief overview of FIT Biotech Oy including business description, key information and facts, and its locations and subsidiaries
• The report reviews current pipeline of FIT Biotech Oy’s human therapeutic division and enlists all their major and minor projects
• The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones
• Special feature on out-licensed and partnered product portfolio
• The report summarizes all the dormant and discontinued pipeline projects
• Latest company statement
• Latest news and deals relating to the FIT Biotech Oy’s pipeline products

Reasons to buy

• Evaluate FIT Biotech Oy’s strategic position with total access to detailed information on its product pipeline
• Assess the growth potential of FIT Biotech Oy in its therapy areas of focus
• Identify new drug targets and therapeutic classes in the FIT Biotech Oy’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
• Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
• Develop strategic initiatives by understanding the focus areas of FIT Biotech Oy and exploit collaboration and partnership opportunities
• Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
• Plan mergers and acquisitions effectively by identifying the most promising pipeline of FIT Biotech Oy
• Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
• Explore the dormant and discontinued projects of FIT Biotech Oy and identify potential opportunities in those areas
• Avoid Intellectual Property Rights related issues

Table of Contents

Table of Contents 2
List of Tables 4
List of Figures 4
FIT Biotech Oy Snapshot 5
FIT Biotech Oy Overview 5
Key Information 5
Key Facts 5
FIT Biotech Oy - Research and Development Overview 6
Key Therapeutic Areas 6
FIT Biotech Oy - Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products - Monotherapy 9
Pipeline Products - Combination Treatment Modalities 10
FIT Biotech Oy - Pipeline Products Glance 11
FIT Biotech Oy - Clinical Stage Pipeline Products 11
Phase II Products/Combination Treatment Modalities 11
FIT Biotech Oy - Early Stage Pipeline Products 12
Preclinical Products/Combination Treatment Modalities 12
Discovery Products/Combination Treatment Modalities 13
FIT Biotech Oy - Drug Profiles 14
FIT-06 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
FIT-06 + LIPO-5 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
tuberculosis vaccine 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
dengue vaccine 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
ebola vaccine 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
malaria vaccine 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
FIT Biotech Oy - Pipeline Analysis 21
FIT Biotech Oy - Pipeline Products by Route of Administration 21
FIT Biotech Oy - Pipeline Products by Molecule Type 22
FIT Biotech Oy - Recent Pipeline Updates 23
FIT Biotech Oy - Dormant Projects 24
FIT Biotech Oy - Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Appendix 26
Methodology 26
Coverage 26
Secondary Research 26
Primary Research 26
Expert Panel Validation 26
Contact Us 26
Disclaimer 27

List of Tables

FIT Biotech Oy, Key Information 5
FIT Biotech Oy, Key Facts 5
FIT Biotech Oy - Pipeline by Indication, 2015 7
FIT Biotech Oy - Pipeline by Stage of Development, 2015 8
FIT Biotech Oy - Monotherapy Products in Pipeline, 2015 9
FIT Biotech Oy - Combination Treatment Modalities in Pipeline, 2015 10
FIT Biotech Oy - Phase II, 2015 11
FIT Biotech Oy - Preclinical, 2015 12
FIT Biotech Oy - Discovery, 2015 13
FIT Biotech Oy - Pipeline by Route of Administration, 2015 21
FIT Biotech Oy - Pipeline by Molecule Type, 2015 22
FIT Biotech Oy - Recent Pipeline Updates, 2015 23
FIT Biotech Oy - Dormant Developmental Projects,2015 24
FIT Biotech Oy, Other Locations 25

List of Figures

FIT Biotech Oy - Pipeline by Top 10 Indication, 2015 7
FIT Biotech Oy - Pipeline by Stage of Development, 2015 8
FIT Biotech Oy - Monotherapy Products in Pipeline, 2015 9
FIT Biotech Oy - Pipeline by Top 10 Route of Administration, 2015 21
FIT Biotech Oy - Pipeline by Top 10 Molecule Type, 2015 22